文献速递创伤与烧伤复苏、休克与脓毒症

经皮递送自推进含凝血酶粉剂提高凝血病与低体温猪模型不可压迫躯干出血的生存率

Percutaneous delivery of self-propelling thrombin-containing powder increases survival from noncompressible truncal hemorrhage in a swine model of coagulopathy and hypothermia.
PubMed 文献 · J Trauma Acute Care Surg · 2022-05-23
一句话结论在凝血病与低体温的猪不可压迫躯干出血模型中,经皮腹腔递送自推进含凝血酶粉剂使中位生存时间从31分钟延长至61分钟(p=0.016),作者认为其是有前景的非手术处理策略,但需进一步测试安全性和有效性。

研究在10头猪(每组5头)中建立V级肝损伤致不可压迫躯干出血(NCTH),关腹形成腹腔积血后分别给予晶体液复苏或晶体液复苏联合自推进含凝血酶粉剂(SPTP),SPTP经CO2动力喷雾装置和导管以Seldinger技术经右上腹置入腹腔积血内递送。SPTP在腹腔内最远分散至35±5.0 cm,提高1小时和3小时生存率(Kaplan-Meier p=0.007),中位生存时间61分钟 vs 31分钟(p=0.016)。作者结论认为SPTP能有效在腹腔积血中分散药物并提高NCTH模型生存率,是有前景的非手术处理策略,需进一步测试安全性和有效性。

要点

  • 在V级肝损伤致NCTH、稀释性凝血病和低体温猪模型中,SPTP组中位生存时间61分钟 vs 对照组31分钟(p=0.016)。
  • SPTP提高1小时和3小时生存率,Kaplan-Meier p=0.007(1小时和3小时均为p=0.007)。
  • SPTP经CO2动力喷雾装置和导管以Seldinger技术经右上腹置入腹腔积血内递送,在腹腔内最远分散至35±5.0 cm。
  • 作者认为SPTP是有前景的NCTH非手术处理策略,但需进一步测试其安全性和有效性。

适用人群与场景

  • 猪模型:V级肝损伤致不可压迫躯干出血(NCTH),伴稀释性凝血病和低体温;10头猪(每组5头)用于生存实验,另1头用于腹腔镜下出血并影像追踪SPTP分散。
  • 原文背景指出NCTH是战场可预防性死亡的主要原因,确定性处理需伤后第一小时内手术,在远程艰苦环境后送时难以实现。

处置流程与药物剂量

  • SPTP经CO2动力喷雾装置和导管以Seldinger技术经右上腹置入腹腔积血内递送,实现经皮腹腔内给药。
  • 动物模型管理:中线剖腹术后缝合关腹形成腹腔积血,给予晶体液复苏,或晶体液复苏联合SPTP。

研究设计与关键结果

  • 研究类型:猪模型实验;10头猪(每组5头)行V级肝损伤致NCTH,随机给予晶体液复苏(对照组)或晶体液复苏联合SPTP;另1头猪腹腔镜下制造出血并行SPTP腹腔内影像追踪。
  • SPTP在腹腔内最远分散至35±5.0 cm。
  • SPTP提高1小时和3小时生存率,Kaplan-Meier p=0.007(1小时和3小时均为p=0.007)。
  • 中位生存时间:SPTP组61分钟 vs 对照组31分钟(p=0.016)。

证据类型、等级与局限

  • 证据类型:动物实验(猪模型);样本量10头(每组5头)加1头影像追踪动物。
  • 局限:原文结论指出需进一步测试SPTP的安全性和有效性(warranting further testing of its safety and efficacy)。

对床旁实践的改变

  • 作者认为SPTP是有前景的NCTH非手术处理策略,需进一步测试其安全性和有效性;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Noncompressible truncal hemorrhage (NCTH) remains a leading cause of preventable death on the battlefield. Definitively managing severe NCTH requires surgery within the first hour after injury, which is difficult when evacuating casualties from remote and austere environments. During delays to surgery, hemostatic interventions that are performed prehospital can prevent coagulopathy and hemorrhagic shock and increase the likelihood that casualties survive to receive definitive care. We previously reported that a self-propelling thrombin-containing powder (SPTP) can be delivered percutaneously into the abdomen as a minimally invasive intervention and can self-disperse through pooled blood to deliver the hemostatic agents thrombin and tranexamic acid locally to noncompressible intracavitary wounds. We hypothesized that, in swine with massive NCTH, dilutional coagulopathy, and hypothermia, delivering SPTP could extend survival times.

METHODS: Ten swine (n = 5 per group) underwent NCTH from a Grade V liver injury following a midline laparotomy. The laparotomy was closed with sutures afterwards, creating a hemoperitoneum, and animals were managed with crystalloid fluid resuscitation, or crystalloid resuscitation and SPTP. Self-propelling thrombin-containing powder was delivered into the closed abdomen using a CO 2 -powered spray device and a catheter placed into the hemoperitoneum, entering through the upper right quadrant using the Seldinger technique. Survival to 1 and 3 hours was recorded. In an additional animal, hemorrhage was created laparoscopically, and SPTP was imaged in situ within the abdomen to visually track dispersion of the particles.

RESULTS: Self-propelling thrombin-containing powder dispersed as far as 35 ± 5.0 cm within the abdomen. It increased survival to 1 and 3 hours (Kaplan-Meier p = 0.007 for both). The median survival time was 61 minutes with SPTP and 31 minutes without ( p = 0.016).

CONCLUSION: Self-propelling thrombin-containing powder effectively disperses medications throughout a hemoperitoneum and increases survival in a model of NCTH. It is a promising strategy for nonsurgical management of NCTH, warranting further testing of its safety and efficacy.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Cau MF, Ali-Mohamad N, Yeh H, et al. Percutaneous delivery of self-propelling thrombin-containing powder increases survival from noncompressible truncal hemorrhage in a swine model of coagulopathy and hypothermia. J Trauma Acute Care Surg. 2022. PMID: 35545803. doi:10.1097/TA.0000000000003670

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。